Published in Cell Immunol on June 01, 1989
Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J Exp Med (1992) 2.03
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest (1996) 1.86
Biochemical basis of synergy between antigen and T-helper (Th) cell-mediated activation of resting human B cells. J Clin Invest (1989) 0.75
Study of induction of activation of human peripheral blood mononuclear cells with a non-activating form of anti-CD3 MoAb in autoimmune thyroid disease (AITD). Clin Exp Immunol (1993) 0.75
A microfilament formation inhibitor, cytochalasin strongly enhances the low-affinity Fc epsilon receptor II (CD23) expression on the human monocyte-like cell line, U937. J Clin Immunol (2000) 0.75
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1. Epidemiologic results. Ann Intern Med (1983) 6.67
Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum (2001) 3.72
Acquired immunodeficiency syndrome in New York City. Evaluation of an active surveillance system. JAMA (1985) 3.45
Functional analysis of human T cell subsets defined by monoclonal antibodies. I. Collaborative T-T interactions in the immunoregulation of B cell differentiation. J Immunol (1980) 2.93
Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med (1995) 2.55
Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population. J Exp Med (1981) 2.35
Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Intern Med (1981) 1.96
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Ann Rheum Dis (2010) 1.90
Ortho-geriatric service--a literature review comparing different models. Osteoporos Int (2010) 1.74
B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response. Ann Rheum Dis (2007) 1.62
Inherited polymorphism of the human T-cell antigen receptor detected by a monoclonal antibody. Proc Natl Acad Sci U S A (1986) 1.61
Protein-synthesizing machinery of thermophilic bacteria. Bacteriol Rev (1968) 1.56
Mixed lens opacities and subsequent mortality. Arch Ophthalmol (2000) 1.49
[Incidence and characteristics of tuberculosis in patients with autoimmune rheumatic diseases]. Rev Clin Esp (2003) 1.48
Dendritic cells are potent antigen-presenting cells for microbial superantigens. J Exp Med (1992) 1.48
CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med (1995) 1.43
Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review. Cancer (2001) 1.41
Unilateral frosted branch angiitis. Am J Ophthalmol (1991) 1.40
Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway. Proc Natl Acad Sci U S A (1995) 1.40
The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest (1994) 1.37
Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy. Curr Cancer Drug Targets (2009) 1.32
OT-CLL: a human T cell chronic lymphocytic leukemia that produces IL 2 in high titer. J Immunol (1982) 1.32
The synthesis of homocystine, cystathionine, and cystine by cultured diploid and heteroploid human cells. Proc Natl Acad Sci U S A (1966) 1.31
Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis (2008) 1.31
Functional analysis of human T cell subsets defined by monoclonal antibodies. II. Collaborative T-T interactions in the generation of TNP-altered-self-reactive cytotoxic T lymphocytes. J Immunol (1981) 1.29
Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction. Ann Rheum Dis (2005) 1.29
Protein synthesis in a subcellular system from Bacillus stearothermophilus. Biochim Biophys Acta (1966) 1.28
Ocular findings in aplastic anemia. Ophthalmologica (2000) 1.25
Desmosomal cadherin binding domains of plakoglobin. J Biol Chem (1996) 1.25
Interleukin 1 production during accessory cell-dependent mitogenesis of T lymphocytes. J Exp Med (1989) 1.24
High-level chloroquine resistance of Plasmodium falciparum malaria acquired in Kenya. N Engl J Med (1982) 1.23
Co-managed care for fragility hip fractures (Rochester model). Osteoporos Int (2010) 1.23
Filamentous phage DNA cloning vectors: a noninfective mutant with a nonpolar deletion in gene III. Virology (1981) 1.22
Botulism and botulism-like illness in chronic drug abusers. Ann Intern Med (1985) 1.21
An epidemiologic evaluation of leprosy in New York City. JAMA (1982) 1.14
Allospecific human T cell lines and clones which mediate HLA-DR restricted helper activity. J Immunol (1982) 1.11
T cell antigen receptors in autoimmunity. J Immunol (1988) 1.11
Direct T helper-B cell interactions induce an early B cell activation antigen. J Exp Med (1986) 1.08
Rapidly progressive herpetic retinal necrosis: a blinding disease characteristic of advanced AIDS. Clin Infect Dis (1998) 1.07
Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol (2000) 1.07
Transmission of hepatitis B virus to classroom contacts of mentally retarded carriers. JAMA (1985) 1.06
Legionnaires' disease in New York City, August-September 1978. Bull N Y Acad Med (1980) 1.06
Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival. Cancer Res (1994) 1.05
Induction of human T cell proliferation by a monoclonal antibody to CD5. J Immunol (1991) 1.05
Characterization of cartilage metabolic response to static and dynamic stress using a mechanical explant test system. J Biomech (1997) 1.05
Association between hepatobiliary cancer and typhoid carrier state. Lancet (1979) 1.02
A cloned major histocompatibility complex-restricted trinitrophenyl-reactive human helper T cell line that activates B cell subsets via two distinct pathways. J Exp Med (1983) 1.02
Human B cell differentiation induced by microbial superantigens: unselected peripheral blood lymphocytes secrete polyclonal immunoglobulin in response to Mycoplasma arthritidis mitogen. Autoimmunity (1992) 1.02
MLC-derived human helper factor(s) that promote B cell differentiation: induction, functional characterization, and role of Ia antigens. J Immunol (1980) 1.01
Functional three-domain single-chain T-cell receptors. Proc Natl Acad Sci U S A (1994) 1.01
Induction of T cell-dependent B cell differentiation by anti-CD3 monoclonal antibodies. J Immunol (1987) 1.01
CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis synovial T cells. Evidence for an antigen-driven response. J Clin Invest (1994) 1.00
Studies on the interaction between ribosomes and 14 CH 3 -F 3 initation factor. Mol Gen Genet (1972) 1.00
Hormonal stimulation necessary for elicitation of maternal nest-building in the mouse (Mus musculus). Anim Behav (1969) 0.98
Lithium substitution and the distribution of sodium in the rat tail artery. Circ Res (1974) 0.98
Impact of community volunteers on immunization rates of children younger than 2 years. Arch Pediatr Adolesc Med (1999) 0.97
Stability of ribosomes and ribosomal ribonucleic acid from Bacillus stearothermophilus. J Bacteriol (1967) 0.97
B cell activation in rheumatoid arthritis patients under infliximab treatment. Clin Exp Rheumatol (2004) 0.96
Fidelity in the translation of messenger ribonucleic acids in mammalian subcellular systems. Biochemistry (1966) 0.96
The role of p23,30-bearing human macrophages in antigen-induced T lymphocyte responses. Cell Immunol (1979) 0.95
Helper T cell-dependent human B cell differentiation mediated by a mycoplasmal superantigen bridge. J Exp Med (1990) 0.95
Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion. J Clin Invest (1989) 0.94
Patterns of uveitis as a guide in making rheumatologic and immunologic diagnoses. Arthritis Rheum (1997) 0.94
Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction. Ann Rheum Dis (2005) 0.93
Acute retinal necrosis after chickenpox in a patient with acquired immunodeficiency syndrome. Arch Ophthalmol (1993) 0.93
Biology of TACE inhibition. Ann Rheum Dis (2001) 0.93
Cellular mechanisms in the in vitro inhibition of pokeweed mitogen-induced B cell differentiation by immunoglobulin for intravenous use. J Immunol (1986) 0.93
Antigen-specific and polyclonal immunoglobulin production induced by a cloned tetanus toxoid-specific T cell line. J Immunol (1983) 0.93
Inhibition of proliferative and plaque-forming cell responses by human bone-marrow-derived lymphocytes from peripheral blood by antisera to the p23, 30 antigen. Proc Natl Acad Sci U S A (1977) 0.93
Cloned allospecific human helper T cell lines induce an MHC-restricted proliferative response by resting B cells. J Immunol (1985) 0.92
CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells. Blood (1996) 0.92
Lithium substitution analysis of Na and K phases in a small artery. Blood Vessels (1974) 0.92
Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis. J Rheumatol (2000) 0.91
A neonatal hepatitis B surveillance and vaccination program: New York City, 1987 to 1988. Am J Public Health (1992) 0.91
Association of the IFIH1-GCA-KCNH7 chromosomal region with rheumatoid arthritis. Ann Rheum Dis (2008) 0.91
T helper cell-induced CD23 (BLAST-2) expression: an activation marker for the high density fraction of human B cells. Clin Immunol Immunopathol (1989) 0.91
Eye involvement in the spondyloarthropathies. Rheum Dis Clin North Am (1998) 0.90
EFFECT OF LOW PROTEIN DIET : (Preliminary Report). Can Med Assoc J (1946) 0.90
Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat. J Immunol (1978) 0.90
Differential proteome of bone marrow mesenchymal stem cells from osteoarthritis patients. Osteoarthritis Cartilage (2008) 0.90
Fidelity during translation of the genetic code. Cold Spring Harb Symp Quant Biol (1966) 0.90
Fas ligand expression and function in systemic lupus erythematosus. J Immunol (1997) 0.89
Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study. Scand J Rheumatol (2009) 0.89
Fas expression and apoptosis in human B cells. Immunol Res (1996) 0.89
Maintenance of the ionic composition of the incubated artery. Can J Physiol Pharmacol (1971) 0.89
Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis. Ann Rheum Dis (2004) 0.89
Compartments of sodium in a small artery. Can J Physiol Pharmacol (1968) 0.89
Functionally restricted, allospecific, human helper T cell lines that amplify either B cell or cytolytic T cell responses. J Exp Med (1983) 0.89
Increased erythrocyte permeability to Li and Na in the spontaneously hypertensive rat. Experientia (1976) 0.88
Successful treatment of metastatic retinoblastoma. Cancer (2000) 0.88
Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha. Proc Natl Acad Sci U S A (2001) 0.88
Sodium binding in the arterial wall. Can J Physiol Pharmacol (1969) 0.87
T helper cell-dependent, microbial superantigen-induced murine B cell activation: polyclonal and antigen-specific antibody responses. J Immunol (1991) 0.87
Increased frequency of V beta 17-positive T cells in patients with rheumatoid arthritis. Arthritis Rheum (1994) 0.86
Triggering of human peripheral blood B cells: polyclonal induction and modulation of an in vitro PFC response. J Immunol (1976) 0.86
Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation. Clin Exp Immunol (1985) 0.86
Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity. Blood (1998) 0.86
Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction. Osteoarthritis Cartilage (2007) 0.85